Does DABRAFENIB Cause Malignant melanoma? 402 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 402 reports of Malignant melanoma have been filed in association with DABRAFENIB (Tafinlar). This represents 2.1% of all adverse event reports for DABRAFENIB.
402
Reports of Malignant melanoma with DABRAFENIB
2.1%
of all DABRAFENIB reports
175
Deaths
135
Hospitalizations
How Dangerous Is Malignant melanoma From DABRAFENIB?
Of the 402 reports, 175 (43.5%) resulted in death, 135 (33.6%) required hospitalization, and 5 (1.2%) were considered life-threatening.
Is Malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 402 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Malignant melanoma?
SILDENAFIL (1,248)
ADALIMUMAB (795)
TADALAFIL (741)
ETANERCEPT (495)
INFLIXIMAB (478)
METHOTREXATE (475)
LENALIDOMIDE (378)
RANITIDINE (352)
RITUXIMAB (291)
TRAMETINIB DIMETHYL SULFOXIDE (281)
Which DABRAFENIB Alternatives Have Lower Malignant melanoma Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB